At a White House event alongside President Donald Trump, Tesla CEO Elon Musk deflected a reporter's question about a recent New York Times report alleging his extensive drug use and legal issues involving some of his children's mothers. When Fox News journalist Peter Doocy attempted to bring up the article, Musk interrupted and criticized the credibility of the Times, referencing its Pulitzer Prize for reporting on the Russia investigation, which he called false.

The Times article claimed Musk regularly used ketamine, ecstasy, and psychedelic mushrooms, with his drug use going beyond occasional instances. It also discussed tensions involving the mothers of his children.

Musk, who played a prominent role in Trump’s Department of Government Efficiency (DOGE), redirected attention to the Times’ Pulitzer Prize, suggesting it may be revoked due to a recent Florida appeals court ruling that allowed Trump’s defamation lawsuit against the Pulitzer board to proceed. The court did not rule on Trump’s claims but noted that a sitting president has the right to continue such legal actions.

At the press conference, Musk announced his decision to step down from his advisory role in the Trump administration to focus on his companies. Despite controversies, Musk was praised by the White House for his commitment to cutting government waste through DOGE.

Musk contributed over $250 million to support Trump’s 2024 campaign, helping him return to the presidency. NBC has not verified the claims made in the Times article, and Musk’s comments have drawn attention for sidestepping the allegations. The White House acknowledged Musk’s contributions to government efficiency but did not address the drug use claims.